Wafik S. El-Deiry/brown.edu
May 19, 2026, 14:35
Wafik S. El-Deiry: This is your 5 Tenets to Advance Evidence-Based Precision Medicine
Wafik S. El-Deiry, Director of the Legorreta Cancer Center at Brown University, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, shared a post on LinkedIn about a recent article by Daniel E. Coral, published in Nature Medicine, adding:
“Five tenets for advancing evidence-based precision medicine
Tenets focus on addressing
- Heterogeneity in risk, response and prognosis;
- Signal robustness;
- Structured statistical benchmarking against key performance indicators;
- Precision trial designs;
- Risks and benefits to individuals and society”
Title: Five tenets for advancing evidence-based precision medicine
Authors: Daniel E. Coral, Jennifer L. Sargent, Julia Carrasco-Zanini, Luis M. Coral, Aaron J. Deutsch, Miriam S. Udler, Giuseppe N. Giordano, Guillaume Pare, Ewan R. Pearson, Maarten van Smeden, Paul W. Franks

Stay updated on Hemostasis Today.
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?
-
Aug 31, 2026, 14:24Akl Fahed: Do Lifelong Differences in LDL Cholesterol Influence the Risk of Venous Thromboembolism?
-
Aug 31, 2026, 14:23Accelerating CAR-T Access Through Policy and System Reform – American Society of Hematology
-
Aug 31, 2026, 14:21Shirya Rashid: Does Bempedoic Acid Influence Venous Thromboembolism Risk?
-
Aug 31, 2026, 14:14Jason Andrade: SINGLE-AF Trial Validates Early Anticoagulation in AF
-
Aug 31, 2026, 14:12Leonardo Roever: Diagnosis and Management of Natural Anticoagulant Deficiencies
-
Aug 31, 2026, 14:07Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery